Bryon A. Tompkins

Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)

Victoria Florea, Angela C. Rieger, Darcy L. DiFede et al. · Circulation Research · 2017 · 202 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Bryon A. Tompkins, Darcy L. DiFede, Aisha Khan et al. · The Journals of Gerontology Series A · 2017 · 160 citations · Full text

Medicine, Geriatric Medicine, Immunology +17

Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty

Samuel Golpanian, Darcy L. DiFede, Aisha Khan et al. · The Journals of Gerontology Series A · 2017 · 106 citations · Full text

Medicine, Geriatric Medicine, Immunology +14

A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration

Makoto Natsumeda, Victoria Florea, Angela C. Rieger et al. · Journal of the American College of Cardiology · 2017 · 81 citations

Medicine, Biology, Cardiology +10

Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy

Bryon A. Tompkins, Angela C. Rieger, Victoria Florea et al. · Journal of the American Heart Association · 2018 · 39 citations · Full text

Medicine, Biotechnology, Cardiology +14